EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Targeting VEGFR-2 in breast cancer: synthesis and in silico and in vitro characterization of quinoxaline-based inhibitors

Ibrahim H Eissa iD, Alaa Elwan iD, Mustafa A Al-Qadhi iD, Dalal Z Husein iD, Fatma G Amin iD, Aisha A Alsfouk iD, Eslam B Elkaeed iD, Hazem Elkady iD, Ahmed M Metwaly iD

RSC Advances · 2025 · 15 (17) · 12896-12916

DOI: 10.1039/d5ra00526d ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2025. Verfasst von Ibrahim H Eissa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University Cairo 11884 Egypt Ibrahimeissa@azhar.edu…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Princess Nourah Bint Abdulrahman University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Design, synthesis and in vitro and in silico studies of novel quinoxaline-based derivatives as antitumor VEGFR-2 inhibitors with apoptotic activities.

Autor:innen und Institutionen

  • Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University Cairo 11884 Egypt Ibrahimeissa@azhar.edu.eg Hazemelkady@azhar.edu.eg.
  • Department of Medicinal Chemistry, Faculty of Pharmacy, Sana'a University 18084 Sana'a Yemen.
  • Chemistry Department, Faculty of Science, New Valley University El-Kharja 72511 Egypt.
  • Physics Department, Faculty of Science, Alexandria University Alexandria Egypt.
  • Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University P. O. Box 84428 Riyadh 11671 Saudi Arabia.
  • Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University P.O. Box 71666 Riyadh 11597 Saudi Arabia.

ORCID-Profile: Ibrahim H Eissa, Alaa Elwan, Mustafa A Al-Qadhi, Dalal Z Husein, Fatma G Amin, Aisha A Alsfouk, Eslam B Elkaeed, Hazem Elkady, Ahmed M Metwaly

Förderung

  • Princess Nourah Bint Abdulrahman University

Zitieren

APA

Eissa, I. H., Elwan, A., Al-Qadhi, M. A., Husein, D. Z., Amin, F. G., Alsfouk, A. A., Elkaeed, E. B., Elkady, H., & Metwaly, A. M. (2025). Targeting VEGFR-2 in breast cancer: synthesis and in silico and in vitro characterization of quinoxaline-based inhibitors. RSC Advances, 15(17), 12896-12916. https://doi.org/10.1039/d5ra00526d

Vancouver

Eissa IH, Elwan A, Al-Qadhi MA, Husein DZ, Amin FG, Alsfouk AA, et al. Targeting VEGFR-2 in breast cancer: synthesis and in silico and in vitro characterization of quinoxaline-based inhibitors. RSC Advances. 2025;15(17):12896-12916. doi:10.1039/d5ra00526d

BibTeX
@article{Eissa2025,
  author = {Eissa, Ibrahim H and Elwan, Alaa and Al-Qadhi, Mustafa A and Husein, Dalal Z and Amin, Fatma G and Alsfouk, Aisha A and Elkaeed, Eslam B and Elkady, Hazem and Metwaly, Ahmed M},
  title = {Targeting VEGFR-2 in breast cancer: synthesis and in silico and in vitro characterization of quinoxaline-based inhibitors},
  journal = {RSC Advances},
  year = {2025},
  volume = {15},
  number = {17},
  pages = {12896--12916},
  doi = {10.1039/d5ra00526d}
}
Kostenlos starten →